CDKN1B and lung adenocarcinoma: The combined mechanistic and pre-clinical data also demonstrate that p27Kip1 may be used clinically as a biomarker for the induction of permanent cell-cycle blockade in lung adenocarcinomas following long-term treatment with Dex.